Many are called, few are chosen: the role of science in drug development decisions
{{output}}
Pharmaceutical firms are extremely selective in deciding which patented drug candidates are taken up into clinical development, given the high costs and risks involved. We argue that the scientific base of drug candidates, and who was responsible for that scie... ...
